Luye Pharma Group Ltd. (LYPHF)
0.3278
0.00 (0.00%)
USD |
OTCM |
Jun 08, 16:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.089B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 22.31% |
| Valuation | |
| PE Ratio | 14.77 |
| PE Ratio (Forward) | |
| PS Ratio | 1.449 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 65.97% |
Profile
| Luye Pharma Group Ltd. is an investment holding company, which engages in the developing, producing, marketing, and selling of pharmaceutical products. It operates through the following segments: Oncology Drugs, Cardiovascular System Drugs, Alimentary Tract and Metabolism Drugs, Central Nervous System Drugs, and Others. The company was founded on June 8, 1994 and is headquartered in Yantai, China. |
| URL | http://www.luye.cn |
| Investor Relations URL | N/A |
| HQ State/Province | Guangdong |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Aug. 27, 2026 (est.) |
| Last Earnings Release | Mar. 31, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jul. 01, 2020 |
Profile
| Luye Pharma Group Ltd. is an investment holding company, which engages in the developing, producing, marketing, and selling of pharmaceutical products. It operates through the following segments: Oncology Drugs, Cardiovascular System Drugs, Alimentary Tract and Metabolism Drugs, Central Nervous System Drugs, and Others. The company was founded on June 8, 1994 and is headquartered in Yantai, China. |
| URL | http://www.luye.cn |
| Investor Relations URL | N/A |
| HQ State/Province | Guangdong |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Aug. 27, 2026 (est.) |
| Last Earnings Release | Mar. 31, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jul. 01, 2020 |
